Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke

NCT05559307 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke, Acute

Interventions

DRUG: Xingnaojing injection

Sponsor

Ying Gao

Collaborators

[object Object]